Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and Taiwan
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Establishing Concordance in Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Promoting Cognition of the Significance of Vaccination and Advancement in Accessibility
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Promoting Understanding and Improving Practices Related to Post-COVID-19 Symptoms
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Japan
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Optimizing Maternal Immunization Practice in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Vaccines Canada
    Patient Preferences for Drug Delivery: Literature Review
    Release Date:
    Review Process: Expert Review Panel
    Research Support for the Professions All
    Global Awards for Research in DMD-AWARD
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Research Rare Disease Canada
    Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Argentina, Brazil, India, Saudi Arabia, Singapore, Taiwan, Turkey
    Invasive Fungal Infections (Global excluding US)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Early Identification and Diagnosis of Non-Alcoholic Steatohepatitis (NASH) in At-Risk Populations
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Advances in Migraine Therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA